Found: 119
Select item for more details and to access through your institution.
Vicarious trauma inside the academe: understanding the impact of teaching, researching and writing violence.
- Published in:
- Higher Education (00181560), 2019, v. 77, n. 5, p. 905, doi. 10.1007/s10734-018-0308-4
- By:
- Publication type:
- Article
Protecting essential information about genetic variants as trade secrets: a problem for public policy?
- Published in:
- Journal of Law & the Biosciences, 2018, v. 5, n. 3, p. 682, doi. 10.1093/jlb/lsz004
- By:
- Publication type:
- Article
RISKS TO THE RETURNS TO MEDICAL INNOVATION: THE CASE OF MYRIAD GENETICS.
- Published in:
- Contemporary Economic Policy, 2017, v. 35, n. 2, p. 345, doi. 10.1111/coep.12189
- By:
- Publication type:
- Article
A "MYRIAD" OF CONTROVERSY OVER THE QUESTION OF HUMAN GENE PATENT ELIGIBILITY: A COMPARISON OF THE DIFFERING APPROACHES IN THE UNITED STATES AND AUSTRALIA.
- Published in:
- Houston Journal of International Law, 2016, v. 38, n. 3, p. 913
- By:
- Publication type:
- Article
In the Aftermath of D'Arcy v. Myriad Genetics Inc: Patenting Isolated Nucleic Acids in Australia.
- Published in:
- European Journal of Risk Regulation, 2016, v. 7, n. 2, p. 451, doi. 10.1017/S1867299X00005882
- By:
- Publication type:
- Article
Biotechnology patents under fire.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 9, p. 925, doi. 10.1038/nbt.3334
- By:
- Publication type:
- Article
Are the gene-patent storm clouds dissipating? A global snapshot.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 4, p. 347, doi. 10.1038/nbt.3182
- By:
- Publication type:
- Article
Patent protection for isolated genes in Australia.
- Published in:
- Journal of Intellectual Property Law & Practice, 2015, v. 10, n. 3, p. 148, doi. 10.1093/jiplp/jpu242
- By:
- Publication type:
- Article
Myriad settles BRCA disputes and moves on.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 3, p. 221, doi. 10.1038/nbt0315-221b
- Publication type:
- Article
D'Arcy v Myriad Genetics Inc: Patenting Genes in Australia.
- Published in:
- Sydney Law Review, 2015, v. 37, n. 1, p. 135
- By:
- Publication type:
- Article
Keeping score, strengthening policy and fighting bad actors over access to research tools.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 2, p. 143, doi. 10.1038/nbt.3131
- By:
- Publication type:
- Article
D'Arcy v Myriad Genetics Inc [2015] HCA 35: The plurality's new factorial approach to patentability rearticulates the question asked in NRDC.
- Published in:
- Journal of Law, Information & Science, 2015, v. 24, n. 1, p. 120
- By:
- Publication type:
- Article
ISOLATING THE PATENTABILITY OF GENETIC MATERIALS: THE D'ARCY V MYRIAD GENETICS SAGA.
- Published in:
- Macquarie Law Journal, 2015, v. 15, p. 105
- By:
- Publication type:
- Article
ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, INC: WHAT ARE THE EFFECTS ON CLONING EXTINCT ANIMALS AND AGRICULTURE NOW THAT CDNA IS PATENTABLE?
- Published in:
- Drake Journal of Agricultural Law, 2014, v. 19, n. 3, p. 347
- By:
- Publication type:
- Article
Australia upholds BRCA1 gene patent.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 11, p. 1076, doi. 10.1038/nbt1114-1076c
- Publication type:
- Article
Patent watch: Australian court upholds Myriad's gene patent.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 11, p. 805, doi. 10.1038/nrd4481
- By:
- Publication type:
- Article
Novel commercially available genomic tests for prostate cancer: a roadmap to understanding their clinical impact.
- Published in:
- BJU International, 2014, v. 114, n. 3, p. 320, doi. 10.1111/bju.12695
- By:
- Publication type:
- Article
FINDERS KEEPERS, OR FINDERS WEEPERS? A PROPOSED ANSWER TO A QUESTION RAISED BY MYRIAD GENETICS.
- Published in:
- Journal of Intellectual Property Law, 2014, v. 22, n. 1, p. 247
- By:
- Publication type:
- Article
CASE STUDY: Myriad stands alone.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 7, p. 620, doi. 10.1038/nbt.2944
- By:
- Publication type:
- Article
Cancer-gene data sharing boosted.
- Published in:
- Nature, 2014, v. 510, n. 7504, p. 198, doi. 10.1038/510198a
- By:
- Publication type:
- Article
Gene patents at the Supreme Court: Association for Molecular Pathology v. Myriad Genetics.
- Published in:
- Journal of Law & the Biosciences, 2014, v. 1, n. 2, p. 183, doi. 10.1093/jlb/lsu007
- By:
- Publication type:
- Article
Fireworks and pharmaceuticals.
- Published in:
- 2014
- Publication type:
- Opinion
THE NEXT STEP IN GENE PATENTS: ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS.
- Published in:
- DePaul Journal of Art, Technology & Intellectual Property Law, 2014, v. 24, n. 2, p. 403
- By:
- Publication type:
- Article
Myriad diversifies, fights rearguard action on patents.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 3, p. 211, doi. 10.1038/nbt0314-211a
- By:
- Publication type:
- Article
GENE-PATENTING AND ACCESS TO HEALTHCARE: ACHIEVING PRECISION.
- Published in:
- Houston Journal of International Law, 2014, v. 36, n. 1, p. 101
- By:
- Publication type:
- Article
DIAGNOSTIC PATENTS AT THE SUPREME COURT.
- Published in:
- Marquette Intellectual Property Law Review, 2014, v. 18, n. 1, p. 1
- By:
- Publication type:
- Article
The Patent Eligibility of Graphene Claims Following the U.S. Supreme Court's Myriad Decision.
- Published in:
- Nanotechnology Law & Business, 2013, v. 10, p. 123
- By:
- Publication type:
- Article
What the Supreme Court's Myriad Decision Means for Nanotechnology Patents.
- Published in:
- Nanotechnology Law & Business, 2013, v. 10, p. 132
- By:
- Publication type:
- Article
Supreme Court Ruling Broadens BRCA Testing Options.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 22, p. 1671, doi. 10.1093/jnci/djt342
- By:
- Publication type:
- Article
US Supreme Court addresses patent eligibility of isolated DNA and cDNA in Myriad V.
- Published in:
- Journal of Intellectual Property Law & Practice, 2013, v. 8, n. 11, p. 811, doi. 10.1093/jiplp/jpt156
- By:
- Publication type:
- Article
DREAMing of a patent-free human genome for clinical sequencing.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 10, p. 884, doi. 10.1038/nbt.2703
- By:
- Publication type:
- Article
The BRCA Gene Patents: Arguments Over Patentability and Social Utility.
- Published in:
- World Medical & Health Policy, 2013, v. 5, n. 3, p. 276, doi. 10.1002/wmh3.54
- By:
- Publication type:
- Article
Are Human Genes Patentable?
- Published in:
- 2013
- By:
- Publication type:
- Opinion
INTELLECTUAL PROPERTY.
- Published in:
- Bench & Bar of Minnesota, 2013, v. 70, n. 7, p. 39
- By:
- Publication type:
- Article
Myriad decision aftershocks ripple through biotech.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 8, p. 663, doi. 10.1038/nbt0813-663
- By:
- Publication type:
- Article
The European BRCA patent oppositions and appeals: coloring inside the lines.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 8, p. 704, doi. 10.1038/nbt.2644
- By:
- Publication type:
- Article
Myriad sues developers of competing breast cancer tests.
- Published in:
- Nature Medicine, 2013, v. 19, n. 8, p. 948, doi. 10.1038/nm0813-948
- By:
- Publication type:
- Article
Heritable genetic changes in the open.
- Published in:
- Nature Methods, 2013, v. 10, n. 8, p. 683, doi. 10.1038/nmeth.2597
- Publication type:
- Article
Supreme Court Rules Against Gene Patents.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 310, n. 4, p. 357, doi. 10.1001/jama.2013.8627
- By:
- Publication type:
- Article
Gene patents disallowed.
- Published in:
- Chemistry & Industry, 2013, v. 77, n. 7, p. 7
- By:
- Publication type:
- Article
Myriad diagnostic concerns.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 7, p. 571, doi. 10.1038/nbt.2638
- Publication type:
- Article
A victory for genes.
- Published in:
- Nature Medicine, 2013, v. 19, n. 7, p. 792, doi. 10.1038/nm.3279
- Publication type:
- Article
Myriad ruling causes confusion.
- Published in:
- Nature, 2013, v. 498, n. 7454, p. 281, doi. 10.1038/498281a
- By:
- Publication type:
- Article
Myriad Further Limits Patent Eligibility.
- Published in:
- BioProcessing Journal, 2013, v. 12, n. 2, p. 37, doi. 10.12665/J122.Merkel
- By:
- Publication type:
- Article
WILL POLICY CONCERNS INVALIDATE MYRIAD GENETICS' GENE PATENTS? A BREAKDOWN OF VARIOUS JUDICIAL APPROACHE STOANALYZING PATENTABLE SUBJECT MATTER.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Not quite a myriad of gene patents.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 5, p. 404, doi. 10.1038/nbt.2568
- By:
- Publication type:
- Article
SHOULD THE NEW ZEALAND PARLIAMENT ALLOW THE INTELLECTUAL PROPERTY OFFICE OF NEW ZEALAND TO CONTINUE TO GRANT PATENTS FOR ISOLATED HUMAN GENES?
- Published in:
- Victoria University of Wellington Law Review, 2013, v. 44, n. 1, p. 91
- By:
- Publication type:
- Article
Gene patents in the dock.
- Published in:
- Nature, 2013, v. 496, n. 7444, p. 150, doi. 10.1038/496150a
- By:
- Publication type:
- Article
Myriad Choices: University Patents Under the Sun.
- Published in:
- Journal of Law & Education, 2013, v. 42, n. 2, p. 313
- By:
- Publication type:
- Article
New year, new science.
- Published in:
- Nature, 2013, v. 493, n. 7430, p. 11, doi. 10.1038/493011a
- By:
- Publication type:
- Article